There is no human experience of overdosage with MOLNUPAC 200/MOLNUPAC 400. Treatment of overdose with MOLNUPAC 200/MOLNUPAC 400 should consist of general supportive measures including the monitoring of the clinical status of the patient. Haemodialysis is not expected to result in effective elimination of NHC.